Company Overview
Snapshot
Founded in January 2017 by Asaf Kleinbort, Shai Levi, and Eviatar Khen, MedOrion operates with 11–50 employees. The company has raised $8.8 million across 7 funding rounds from 6 investors.
Business overview
MedOrion offers an AI-based Health Behavior Management (HBM) platform designed for health plans and risk-bearing providers. Its SaaS solution integrates complex health data, individual behavior, and external factors to generate personalized communication and inform long-term strategies. The company operates within the Health Tech & Life Sciences sector, focusing on digital healthcare and patient engagement, serving markets such as the United States and Israel.
Strategic signal
In November 2024, MedOrion expanded its behavioral science software by releasing a new CAHPS solution. This development signals the company's continuous innovation in enhancing its platform to address critical aspects of patient experience and satisfaction, which is a key differentiator in the competitive healthcare software market and indicates a strategic move to broaden its product offerings and market reach.
Log in to access full profile ›Company Intelligence Q&A
- What is MedOrion's core offering?
- MedOrion provides an AI-based Health Behavior Management (HBM) platform that helps health plans and risk-bearing providers influence member health through intelligent, personalized communication and strategic planning.
- What significant product enhancement did MedOrion announce recently?
- In November 2024, MedOrion announced the release of a new CAHPS solution, expanding its behavioral science software capabilities.
- What was a key milestone for MedOrion in early 2022?
- In March 2022, MedOrion announced the launch of its first Health Behavior Management software specifically for U.S.-based health plans.